Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1 + 318 word(s) 318 2020-12-15 07:30:20 |
2 change title + 305 word(s) 623 2020-12-22 06:57:53 | |
3 update layout -11 word(s) 612 2020-12-22 09:53:26 | |
4 update layout + 9 word(s) 621 2020-12-23 07:11:10 |

Video Upload Options

Do you have a full video?


Are you sure to Delete?
If you have any further questions, please contact Encyclopedia Editorial Office.
Xu, R. MN1 C-Terminal Truncation Syndrome. Encyclopedia. Available online: (accessed on 25 April 2024).
Xu R. MN1 C-Terminal Truncation Syndrome. Encyclopedia. Available at: Accessed April 25, 2024.
Xu, Rita. "MN1 C-Terminal Truncation Syndrome" Encyclopedia, (accessed April 25, 2024).
Xu, R. (2020, December 22). MN1 C-Terminal Truncation Syndrome. In Encyclopedia.
Xu, Rita. "MN1 C-Terminal Truncation Syndrome." Encyclopedia. Web. 22 December, 2020.
MN1 C-Terminal Truncation Syndrome

MN1 C-terminal truncation (MCTT) syndrome is a condition characterized by intellectual disability, developmental delay, distinctive facial features, and brain abnormalities.

genetic conditions

1. Introduction

Most people with MCTT syndrome have mild to moderate intellectual disability. Many affected individuals are nonverbal, but some have speech limited to one or two words or communicate using sign language. Most children with this condition have delayed development of motor skills, such as crawling or walking, but are able to walk by age 2 or 3. However, they often need help with fine-motor skills, such as getting dressed or using a fork when eating.

Individuals with MCTT syndrome often have distinctive facial features that include a sunken appearance of the middle of the face (midface hypoplasia); a high arch in the roof of the mouth (high-arched palate); outside corners of the eyes that point downward (downslanting palpebral fissures); widely spaced eyes (hypertelorism); shallow and bulging eyes (exophthalmos); a short, upturned nose; and small, low-set ears. Some affected individuals have dental abnormalities, such as cone-shaped (conical), jagged, or crowded teeth. Rarely, people with MCTT syndrome have premature fusion of certain skull bones (craniosynostosis).

People with MCTT syndrome often have characteristic brain abnormalities. The surface of the brain normally has many ridges or folds, called gyri. A common brain abnormality in people with MCTT syndrome is called perisylvian polymicrogyria, in which an area of the brain called the perisylvian region develops too many gyri, and the folds are irregular and unusually small. Individuals with MCTT syndrome can also have a malformation of the part of the brain that coordinates movement (the cerebellum). This malformation, called atypical rhombencephalosynapsis, is characterized by tissue loss in the central part of the cerebellum (known as the vermis) and fusion of the two sides of the cerebellum. These brain abnormalities likely contribute to the movement problems and intellectual disability that are common in MCTT syndrome. 

Less common features of MCTT syndrome include hearing loss, seizures, abnormal curvature of the spine, and heart abnormalities.

2. Frequency

The prevalence of MCTT syndrome is unknown, although it is thought to be a rare disorder. At least 25 affected individuals have been described in the scientific literature.

3. Causes

MCTT syndrome is caused by mutations in the MN1 gene. This gene provides instructions for making a protein whose function is unclear.  Based on its interaction with other proteins, the MN1 protein is thought to play a role in regulating the activity of other genes, particularly those needed for the development of the skull and brain.

All MN1 gene mutations that cause MCTT syndrome occur near the end (terminal) portion of the gene. As a result, an abnormally short (truncated) protein is produced. These mutations are reflected in the condition name, MN1 C-terminal truncation syndrome.

Research shows that a shortened MN1 protein cannot interact with other proteins, leading to a buildup of the abnormal MN1 protein in the cell nucleus. It is likely that without the normal function of the MN1 protein, the activity of certain genes involved in the development of the skull and brain is unregulated, leading to the signs and symptoms of MCTT syndrome.

3.1. The Gene Associated with MN1 C-Terminal Truncation Syndrome


4. Inheritance

MCTT syndrome is inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder.

Most cases of this condition result from new (de novo) mutations in the MN1 gene that occur during the formation of reproductive cells (eggs or sperm) in an affected individual's parent or in early embryonic development. These cases occur in people with no history of the disorder in their family.

5. Other Names for This Condition

  • craniofacial defects, dysmorphic ears, structural brain abnormalities, expressive language delay, and impaired intellectual development
  • MCTT syndrome


  1. Mak CCY, Doherty D, Lin AE, Vegas N, Cho MT, Viot G, Dimartino C,Weisfeld-Adams JD, Lessel D, Joss S, Li C, Gonzaga-Jauregui C, Zarate YA, EhmkeN, Horn D, Troyer C, Kant SG, Lee Y, Ishak GE, Leung G, Barone Pritchard A, Yang S, Bend EG, Filippini F, Roadhouse C, Lebrun N, Mehaffey MG, Martin PM, Apple B, Millan F, Puk O, Hoffer MJV, Henderson LB, McGowan R, Wentzensen IM, Pei S, ZahirFR, Yu M, Gibson WT, Seman A, Steeves M, Murrell JR, Luettgen S, Francisco E,Strom TM, Amlie-Wolf L, Kaindl AM, Wilson WG, Halbach S, Basel-Salmon L, Lev-ElN, Denecke J, Vissers LELM, Radtke K, Chelly J, Zackai E, Friedman JM, BamshadMJ, Nickerson DA; University of Washington Center for Mendelian Genomics, ReidRR, Devriendt K, Chae JH, Stolerman E, McDougall C, Powis Z, Bienvenu T, Tan TY, Orenstein N, Dobyns WB, Shieh JT, Choi M, Waggoner D, Gripp KW, Parker MJ, StolerJ, Lyonnet S, Cormier-Daire V, Viskochil D, Hoffman TL, Amiel J, Chung BHY,Gordon CT. MN1 C-terminal truncation syndrome is a novel neurodevelopmental andcraniofacial disorder with partial rhombencephalosynapsis. Brain. 2020 Jan1;143(1):55-68. doi: 10.1093/brain/awz379. Erratum in: Brain. 2020 Mar1;143(3):e24.
  2. Mak CCY, Fung JLF, Lee M, Lin AE, Amiel J, Doherty D, Gordon CT, Chung BHY.MN1 C-Terminal Truncation Syndrome. 2020 Aug 13. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews®[Internet]. Seattle (WA): University of Washington, Seattle; 1993-2020. Availablefrom
  3. Miyake N, Takahashi H, Nakamura K, Isidor B, Hiraki Y, Koshimizu E, Shiina M, Sasaki K, Suzuki H, Abe R, Kimura Y, Akiyama T, Tomizawa SI, Hirose T, HamanakaK, Miyatake S, Mitsuhashi S, Mizuguchi T, Takata A, Obo K, Kato M, Ogata K,Matsumoto N. Gain-of-Function MN1 Truncation Variants Cause a RecognizableSyndrome with Craniofacial and Brain Abnormalities. Am J Hum Genet. 2020 Jan2;106(1):13-25. doi: 10.1016/j.ajhg.2019.11.011.
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to :
View Times: 495
Entry Collection: MedlinePlus
Revisions: 4 times (View History)
Update Date: 23 Dec 2020